Prescription Drugs:

Prices and Regulation in Canada and Europe

T-HEHS-94-213: Published: Jul 27, 1994. Publicly Released: Jul 27, 1994.

Additional Materials:


Office of Public Affairs
(202) 512-4800

GAO discussed international regulation of prescription drug prices, focusing on the effects on pharmaceutical prices, expenditures, and research and development. GAO noted that: (1) brand-name prescription drugs are usually priced higher in the United States than in other countries; (2) although five countries have adopted policies and regulations to control prescription drug prices and expenditures, the policies have been more effective in limiting prices than expenditures because of the increase in drug use; (3) the effect of prescription drug prices on pharmaceutical firms' research and development costs is difficult to calculate; (4) lower drug prices cause a decrease in drug firms' research and development costs; and (5) the effect of similar policies on drug pricing in the United States could differ from the other countries' experiences because of the size of the U.S. market and institutional differences.

Mar 19, 2018

Mar 8, 2018

Feb 20, 2018

Feb 8, 2018

Feb 5, 2018

Jan 30, 2018

Jan 23, 2018

Jan 17, 2018

Jan 16, 2018

Looking for more? Browse all our products here